Leanna J. Standish

Bastyr University — United States

Medicine · Health Sciences

36h-index3.9kcitations128works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Complementary and Alternative Medicine Studies(44), Herbal Medicine Research Studies(15), Immune Cell Function and Interaction(13), Cancer survivorship and care(12), RNA Interference and Gene Delivery(12)

Publications126 total

Naturopathic Oncology for Advanced Cancers: Survival Outcomes from the Canadian/US Integrative Oncology Study
CAND Journal·2025· 1 citedOpen Access
A Comprehensive Description of Naturopathic Care for Advanced Cancers: Outcomes from the Canadian/US Integrative Oncology Study
CAND Journal·2025· 1 citedOpen Access
Septal lesion-induced hyper-reactivity anatomical and neurochemical aspects.
Scholarworks (University of Massachusetts Amherst)·2023· 1 citedOpen Access
Supplementary Figure 4 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Supplementary Figure 1 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Supplementary Figure 3 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Supplementary Data from Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells
2023Open Access
Supplementary Figure 2 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Supplementary Figure 5 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Supplementary Data from Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells
2023Open Access
Supplementary Figure 4 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Data from Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells
2023Open Access
Data from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Supplementary Figure 3 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Supplementary Figure 2 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Data from Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells
2023Open Access
Supplementary Table 1 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Data from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Supplementary Figure 1 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
Supplementary Figure 5 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Carlo Calabrese(9), Leila Kozak(9), Erin Sweet(9), Cynthia A. Wenner(8), Ruth E. Patterson(6), Marian L. Neuhouser(5), Monique M. Hedderson(5), Mark R. Martzen(5), William E. Lafferty(5), M. Robyn Andersen(5), Stephen M. Schwartz(4), Hailing Lu(4), Todd L. Richards(4), Carolyn J. Torkelson(4), Lois Downey(4), Donald L. Patrick(4), Sean Congdon(4), Deborah J. Bowen(3), Wendy Weber(3), Ekram Gad(3)